Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov;18(11):2193-8.
doi: 10.1007/s10856-007-3075-9. Epub 2007 Jul 3.

Preparation and characterization of rapamycin-loaded PLGA coating stent

Affiliations

Preparation and characterization of rapamycin-loaded PLGA coating stent

C J Pan et al. J Mater Sci Mater Med. 2007 Nov.

Abstract

In this study, using polylactic acid-co-glycolic acid (PLGA) with a molecular weight of 95,800 Da as drug carrier, three dose (low, moderate, high) rapamycin-eluting stents and the corresponding coating films were prepared. The pre- and post-expansion morphology of the rapamycin-eluting stent was examined by scanning electron microscopy (SEM), indicating that the coating was very smooth and uniform. The coating had the ability to withstand the compressive and tensile strains imparted without cracking from the stent during expansion process. There were many voids on stent coating surface after released for 18 days in release medium. The thermodynamics data of the stent coating film measured by differential scanning calorimetry (DSC) showed a lack of measurable solubility of rapamycin in the PLGA matrix. The release behavior of rapamycin from stent surface had a two phase release profile with a burst release period of about 2 days, followed by a sustained and slow release phase. The mass loss behavior of PLGA appeared linear throughout most of the degradation period, corresponding to an approximately constant mass loss rate. The platelet adhesion tests showed that the rapamycin-eluting films may have a good blood compatibility compared with control samples. Take into these results account, this novel rapamycin-eluting may be a good candidate to resolve in-stent restenosis.

PubMed Disclaimer

References

    1. Int J Cardiol. 2005 Mar 10;99(1):9-17 - PubMed
    1. Heart. 2003 Feb;89(2):218-24 - PubMed
    1. Biomaterials. 1996 Jan;17(2):103-14 - PubMed
    1. Circulation. 1999 Apr 27;99(16):2164-70 - PubMed
    1. J Control Release. 2004 Jul 23;98(1):67-74 - PubMed

Publication types

MeSH terms

LinkOut - more resources